Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of an Intravenous Solution of JNJ-39588146 or Placebo in Patients With Heart Failure
This study has been completed.
Study NCT01120210   Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received on May 6, 2010.   Last Updated on September 6, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Heart Failure
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Interventions listed in this trial
JNJ-39588146 5 ng/kg/min
JNJ-39588146 15 ng/kg/min
JNJ-39588146 30 ng/kg/min
Placebo
JNJ-39588146 5, 15, or 30 ng/kg/min
Sponsors listed in this trial
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services